UPDATE: Corbus Pharma (CRBP) Mentioned Cautiously by Adam Feuerstein

October 25, 2016 8:49 AM EDT
Get Alerts CRBP Hot Sheet
Trade CRBP Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

(Updated - October 25, 2016 8:54 AM EDT)

Corbus Pharma (NASDAQ: CRBP) was mentioned cautiously in an article by Adam Feuerstein. According to to the report, an unnamed fund manager who is short the stock said the company's only pipeline drug, Resunab, doesn't work.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hedge Funds, Short Sales, Trader Talk

Related Entities

Adam Feuerstein

Add Your Comment